雜志介紹

Cell Biology And Toxicology雜志介紹

《Cell Biology And Toxicology》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱細(xì)胞生物學(xué)和毒理學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-TOXICOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為5.3，最新CiteScore 指數(shù)為9.9。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Reduced LINC00467 elevates microRNA-125a-3p to suppress cisplatin resistance in non-small cell lung cancer through inhibiting sirtuin 6 and inactivating the ERK1/2 signaling pathway

  Author: Xue, Feng; Yang, Chuan; Yun, Keli; Jiang, Cailing; Cai, Rui; Liang, Ming; Wang, Quan; Bian, Weixin; Zhou, Hang; Liu, Zhipeng; Zhu, Lin

• MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia

  Author: Lu, Qirong; Guo, Pu; Wang, Xiaohui; Ares, Irma; Lopez-Torres, Bernardo; Martinez-Larranaga, Maria-Rosa; Li, Tingting; Zhang, Yuanyuan; Wang, Xu; Anadon, Arturo; Martinez, Maria-Aranzazu

• Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms

  Author: Wu, Sisi; Lan, Jie; Li, Lingyu; Wang, Xiaoxiao; Tong, Mingming; Fu, Li; Zhang, Yanjing; Xu, Jiayi; Chen, Xuemei; Chen, Hongying; Li, Ruli; Wu, Yao; Xin, Juanjuan; Yan, Xin; Li, He; Xue, Kunyue; Li, Xue; Zhuo, Caili; Jiang, Wei

• The cytotoxicity of zinc oxide nanoparticles to 3D brain organoids results from excessive intracellular zinc ions and defective autophagy

  Author: Liu, Liangliang; Wang, Junkang; Zhang, Jiaqi; Huang, Chaobo; Yang, Zhaogang; Cao, Yi

英文介紹

Cell Biology And Toxicology雜志英文介紹

Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.